University Of Michigan Rogel Cancer Center
Clinical trials sponsored by University Of Michigan Rogel Cancer Center, explained in plain language.
-
Targeted radiation zaps spots to slow advanced prostate cancer
Disease control CompletedThis study tested if adding targeted radiation to standard drug therapy helps men with advanced prostate cancer that has spread to a few spots. It compared the combination to drug therapy alone. The goal was to see if the radiation could better control the cancer and delay its pr…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Could a simple dietary supplement protect transplant patients from a dangerous side effect?
Disease control CompletedThis study tested whether a commercially available potato starch supplement could help prevent a serious complication called graft-versus-host disease (GVHD) in patients receiving a stem cell transplant. Researchers gave the supplement to 107 patients starting just before their t…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New website aims to keep prostate cancer patients on track
Disease control CompletedThis small pilot study tested a new website designed to help men with low-risk prostate cancer who are on 'active surveillance.' Active surveillance means monitoring the cancer closely instead of treating it right away. The study checked if the tool was easy to use and helpful fo…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Diabetes drug tested as potential leukemia fighter
Disease control CompletedThis study tested whether metformin, a common and inexpensive diabetes medication, could help control chronic lymphocytic leukemia (CLL). It involved 37 adults with either relapsed CLL or a specific genetic type of untreated CLL. The goal was to see if taking metformin could slow…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Immunotherapy boost tested for tough throat cancers
Disease control CompletedThis study tested whether adding the immunotherapy drug nivolumab to the standard treatment of radiation and chemotherapy could better control high-risk HPV-related throat cancer and keep it from returning. It involved 26 adults with advanced-stage cancer of the tonsils or base o…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New drug cocktail tested for Tough-to-Treat bile duct cancer
Disease control CompletedThis study tested a combination of four drugs for people with advanced bile duct cancer that had worsened after their first treatment. The main goals were to see if the drug mix was safe and if it could help control the cancer and extend life. It involved 34 participants and comb…
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
MRI guides stronger radiation blast to tough cancer spots
Disease control CompletedThis study tested a new way to give radiation therapy to people with advanced head and neck cancer that has a poor outlook. Doctors used a special MRI scan to find parts of the tumor that might resist standard radiation and then gave a higher, focused dose just to those areas. Th…
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Study aims to stop unnecessary thyroid surgeries
Disease control CompletedThis study tested an educational tool called CQUPLE to help patients with low-risk thyroid cancer understand their treatment options. Fifty newly diagnosed patients were randomly assigned to either receive this tool or standard care before their surgeon visit. Researchers measure…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
New nerve surgery offers hope to end chronic pain after mastectomy
Symptom relief CompletedThis study tested a new surgical technique to treat chronic pain that can develop after breast removal surgery (mastectomy). The surgery, called a Regenerative Peripheral Nerve Interface (RPNI), aims to treat painful nerve endings. Researchers followed 26 women for about a year t…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Young survivors try Finger-Pressure therapy to fight cancer fatigue
Symptom relief CompletedThis small pilot study tested whether young cancer survivors could use a simple, self-applied finger-pressure technique called acupressure to help manage their persistent fatigue. Forty-two survivors aged 15-39 who had finished treatment but still felt tired used a special app an…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
Finger-Pressure therapy trial offers hope for cancer drug side effects
Symptom relief CompletedThis study tested whether self-administered acupressure could reduce joint pain and stiffness in postmenopausal breast cancer patients experiencing these side effects from their aromatase inhibitor medications. Fifty participants were randomly assigned to receive either real or s…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated Mar 24, 2026 12:03 UTC
-
Fingertip pressure tested to ease cancer Survivors' exhaustion
Symptom relief CompletedThis study tested whether acupressure, a technique using finger pressure on specific body points, could help reduce severe fatigue in women who have completed treatment for ovarian cancer. It involved 171 survivors who reported significant fatigue. Researchers measured changes in…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC
-
Can a pen and paper ease the hidden scars of cancer?
Symptom relief CompletedThis study tested if a simple, at-home writing program could help young cancer survivors (ages 15-39) who are struggling with body image distress and anxiety. The goal was to see if this four-week program was practical and acceptable for participants to use. The research aimed to…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated Mar 19, 2026 14:55 UTC
-
Web program aims to get cancer Patients' families tested for genetic risk
Knowledge-focused CompletedThis study tested a web-based program designed to help cancer patients share information about inherited cancer risk with their family members. The program provided education and support to encourage relatives to get low-cost genetic testing. Researchers compared different versio…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Common heartburn & pain pills put to the test in colon cancer prevention hunt
Knowledge-focused CompletedThis small, early study aimed to find biological clues in the colon that might show if a combination of low-dose aspirin and omeprazole (a common heartburn medicine) could help prevent polyps from turning into cancer. It involved 21 adults with a history of many colon polyps. Par…
Phase: EARLY_PHASE1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Michigan study tests new ways to boost cancer gene testing
Knowledge-focused CompletedThis study tested two new methods to encourage people at higher risk for hereditary cancers to get recommended genetic testing. Over 800 participants in Michigan were randomly assigned to either use a special website, receive two coaching phone calls, or get standard information.…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC